AndroGel Makers, Buyers Clash Over FTC Getting Discovery

By Khorri Atkinson · April 2, 2021, 10:21 PM EDT

Pharmaceutical companies scolded plaintiffs waging an antitrust fight over testosterone treatment AndroGel for asking a Pennsylvania federal court to let them share sensitive records obtained through discovery with the Federal Trade Commission....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Letter

Case Information

Case Title

KING DRUG COMPANY OF FLORENCE, INC. et al v. ABBOTT LABORATORIES et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 07, 2019

Recent Articles By Khorri

July 28, 2022
Judge Mulls Feds', Tobacco Cos.' Decree On Health Warnings
July 01, 2022
Ky. Trial Judge Vacancy Tees Up Likely Biden-McConnell Deal
June 10, 2022
Fed. Circ. Eyes Eligibility Of Stanford's Transplant Testing IP
May 25, 2022
11th Circ. Nixes Suit By Atty Who Ended Mental Health Checks
May 23, 2022
Judge Skeptically Probes Fate Of FDA's Cigar Regulation
May 16, 2022
Providers Say 9th Circ. Ruling Helps BCBS Antitrust Case
April 11, 2022
DOJ Attys Escape Subpoena To Testify In Wage-Fixing Trial
March 24, 2022
Endo Wins Dismissal Of FTC's Suit Over Impax Opioid Deal
March 22, 2022
3rd Circ. Upholds FTC Bid To Pause NJ Hospital Merger
March 18, 2022
DC Judge Ends 'Dormant' LabMD Suit Against FTC Attys